Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus [Phase 4]
Phase 4 trial evaluating whether valsartan reduces proteinuria in patients with hypertension and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension [Phase 3]
Phase 3 clinical trial comparing valsartan alone to valsartan plus hydrochlorothiazide in adults with hypertension has completed. The sponso…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of fluvastatin, valsartan, and their combination in dyslipidemic patients with hyp…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension [Phase 3]
A Phase 3 trial evaluating valsartan for treating hypertension in children aged 1 to 5 years has completed (up to 56 weeks of treatment).
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Comparison of Two Treatment Strategies in Hypertensive Patients [Phase 4]
A Phase 4 clinical trial comparing two hypertension treatment strategies sponsored by Novartis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension [Phase 3]
A Phase 3 clinical trial update evaluating safety and efficacy of various combinations of valsartan, hydrochlorothiazide, and amlodipine in …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension [Phase 4]
This update notes the completion of a Phase 4 trial comparing valsartan plus amlodipine versus amlodipine alone for hypertension.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP) [Phase 4]
Phase 4 trial update investigating whether reducing blood pressure affects high-sensitivity C-reactive protein (hsCRP) levels in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone [Phase 3]
Phase 3 trial update evaluating the valsartan/hydrochlorothiazide combination in hypertensive patients not adequately controlled on valsarta…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Antialbuminuric Effects of Valsartan and Lisinopril [Phase 4]
Phase 4 trial update evaluating the antialbuminuric effects of valsartan and lisinopril in hypertension and early diabetic nephropathy; the …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria. [Phase 4]
A Phase 4 trial comparing valsartan/hydrochlorothiazide to amlodipine in patients with hypertension, diabetes, and albuminuria has completed…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure [Phase 4]
Phase 4 study update evaluating vascular and renal effects and overall safety of valsartan in adults with hypertension; the trial status is …
-
FDA approval · 2011-11-02FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, In…
-
FDA approval · 2011-11-02FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental NDA for Verapamil Hydrochloride from Exela Pharma Sciences, LLC under NDA 018925.
-
CLINICAL_TRIALS trial_result · 2011-11-02Clinical Trial Update: Survey to Assess Why People Are Not Responding to Treatment in Hypertension
A Bayer-sponsored clinical trial update summarizes a survey exploring why some patients with hypertension do not respond to treatment. The s…
-
FDA approval · 2011-11-01FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) submitted by Cosett…
-
FDA label_change · 2011-10-31FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2011-10-31FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC, resulting in an approved label…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Device Based Therapy in Hypertension Extension Trial [NA]
CVRx's device-based therapy extension trial for hypertension has completed.
-
FDA approval · 2011-10-28FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for CARTIA XT (diltiazem hydrochloride) under ANDA074752.
-
FDA approval · 2011-10-28FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corp…
-
FDA approval · 2011-10-28FDA Approved: FELODIPINE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s original application for Felodipine (generic), a calcium channel blocker for hypertension and angina.
-
FDA approval · 2011-10-27FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for a generic Losartan Potassium and Hydrochlorothiazide product manufactured by Teva Pharmaceutical…
-
FDA approval · 2011-10-27FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Amlodipine Besylate and Benazepril Hydrochloride by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-10-26FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for losartan potassium and hydrochlorothiazide from NorthStar Rx LLC. Losartan potassium and hyd…